ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
28,625
0,00
(0,00%)
Fermé 30 Septembre 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
28,625
Prix Achat
-
Prix Vente
-
Volume échangé
-
0,00 Fourchette du Jour 0,00
24,2942 Plage de 52 semaines 30,67
Cap du marché
Clôture Veille
28,625
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
2 640
Actions en circulation
360 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
5,47
Bénéfice par action (BPA)
5,23
Chiffre d'affairess
626k
Bénéfice net
1,88M

À propos de ProShares Global Listed Private Equity

The investment seeks investment results, before fees and expenses, that track the performance of the LPX Direct Listed Private Equity Index (the index). The index consists of up to 30 qualifying listed private equity companies. The fund invests insecurities that ProShare Advisors believes, in combin... The investment seeks investment results, before fees and expenses, that track the performance of the LPX Direct Listed Private Equity Index (the index). The index consists of up to 30 qualifying listed private equity companies. The fund invests insecurities that ProShare Advisors believes, in combination, should track the performance of the index. It will invest at least 80% of its total assets in component securities. The fund will concentrate its investments in a particular industry or group of industries, country or region to approximately the same extent as the index is so concentrated. It is non-diversified. Show more

Secteur
Mgmt Invt Offices, Open-end
Industrie
Mgmt Invt Offices, Open-end
Siège social
Wilmington, Delaware, USA
Fondé
-
ProShares Global Listed Private Equity est coté dans le secteur Mgmt Invt Offices, Open-end de la American Stock Exchange avec le ticker PEX. Le dernier cours de clôture d'ProShares Global Listed ... était de US$28,63. Au cours de la dernière année, les actions de ProShares Global Listed ... ont été négociées dans une fourchette de prix de US$ 24,2942 à US$ 30,67.

ProShares Global Listed ... compte actuellement 360 000 actions en circulation. La capitalisation boursière d'ProShares Global Listed ... est de US$10,31 million. ProShares Global Listed ... a un ratio cours/bénéfice (ratio PE) de 5.47.

PEX Dernières nouvelles

Apex Bioventures Acquisition Corp. Announces Stockholder Approval to Liquidate and Dissolve

HILLSBOROUGH, Calif., June 2 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Amex: PEX) (the "Company") announced that at a special meeting of stockholders held today...

Apex Bioventures Acquisition Corporation Receives Notice of Extension from NYSE Amex

HILLSBOROUGH, Calif., May 11 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Amex: PEX) (the "Company") announced today that it has received notice from NYSE Amex LLC...

Apex Bioventures Acquisition Corp. Sets Date for Special Meeting of Stockholders to Approve Dissolution

HILLSBOROUGH, Calif., May 7 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Amex: PEX) ("Apex") announced today that a special meeting of stockholders will be held at...

Apex Bioventures Acquisition Corp. To Seek Stockholder Approval To Liquidate and Dissolve

HILLSBOROUGH, Calif., March 5 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Alternext US: PEX) ("Apex") announced today that its board of directors has determined that...

Apex Receives Non-Compliance Letter from NYSE Alternext US

HILLSBOROUGH, Calif., Feb. 13 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Alternext US: PEX) announced today that it has received notice from NYSE Alternext US LLC...

Apex Bioventures Acquisition Corporation Signs Letter of Intent for Business Combination

HILLSBOROUGH, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (AMEX:PEX) announced today that, on December 13, 2008, it entered into a letter of intent with a...

Apex Bioventures Announces Trust Investment Details

HILLSBOROUGH, Calif., Oct. 14 /PRNewswire-FirstCall/ -- In light of recent events impacting the global financial markets, Apex Bioventures Acquisition Corp. (AMEX:PEX), a publicly traded special...

Apex Bioventures and Dynogen Pharmaceuticals Mutually Terminate Merger Agreement

Apex Bioventures Acquisition Corp. (AMEX: PEX), a publicly traded special purpose acquisition company with healthcare industry expertise, announced today its mutual agreement...

Apex Bioventures and Dynogen Pharmaceuticals Announce Definitive Merger Agreement

Apex Bioventures Acquisition Corp. (AMEX: PEX), a publicly traded special purpose acquisition company with healthcare industry expertise, and Dynogen Pharmaceuticals, Inc., a...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.725-2.4701873935329.3529.6228.048673528.93237918SP
4-0.375-1.293103448282929.6228.048302428.8421308SP
12-0.665-2.2703994537429.2929.6926.43264028.8436249SP
26-1.005-3.3918326020929.6330.6726.43274729.33498472SP
522.4059.1723874904726.2230.6724.2942249728.60127432SP
156-8.115-22.08764289636.7438.6423.03322629.77068146SP
260-6.0638-17.480570097634.688839.011517.49268229.78582844SP
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock